[PHARMA] YoY Annualized Quarter Result on 30-Jun-2005 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-Aug-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2005
Quarter
30-Jun-2005 [#2]
Profit Trend
QoQ- -9.29%
YoY- -16.57%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
Revenue 1,326,230 1,112,932 1,003,774 941,312 739,898 619,574 596,192 14.24%
PBT 96,924 44,822 34,354 65,122 73,866 62,520 60,716 8.09%
Tax -32,046 -17,402 -10,728 -22,940 -27,334 -22,450 -23,738 5.12%
NP 64,878 27,420 23,626 42,182 46,532 40,070 36,978 9.81%
-
NP to SH 63,304 25,418 21,870 38,820 46,532 40,070 36,978 9.36%
-
Tax Rate 33.06% 38.82% 31.23% 35.23% 37.00% 35.91% 39.10% -
Total Cost 1,261,352 1,085,512 980,148 899,130 693,366 579,504 559,214 14.50%
-
Net Worth 362,623 314,515 316,549 256,416 240,230 195,341 159,405 14.66%
Dividend
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
Div 38,508 32,093 24,596 21,453 9,084 - - -
Div Payout % 60.83% 126.26% 112.47% 55.26% 19.52% - - -
Equity
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
Net Worth 362,623 314,515 316,549 256,416 240,230 195,341 159,405 14.66%
NOSH 106,968 106,978 106,942 102,157 100,937 100,175 49,970 13.51%
Ratio Analysis
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
NP Margin 4.89% 2.46% 2.35% 4.48% 6.29% 6.47% 6.20% -
ROE 17.46% 8.08% 6.91% 15.14% 19.37% 20.51% 23.20% -
Per Share
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
RPS 1,239.83 1,040.34 938.61 921.43 733.03 618.49 1,193.09 0.64%
EPS 59.18 23.76 20.44 38.00 46.10 40.00 74.00 -3.65%
DPS 36.00 30.00 23.00 21.00 9.00 0.00 0.00 -
NAPS 3.39 2.94 2.96 2.51 2.38 1.95 3.19 1.01%
Adjusted Per Share Value based on latest NOSH - 102,361
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
RPS 92.02 77.22 69.65 65.31 51.34 42.99 41.37 14.23%
EPS 4.39 1.76 1.52 2.69 3.23 2.78 2.57 9.32%
DPS 2.67 2.23 1.71 1.49 0.63 0.00 0.00 -
NAPS 0.2516 0.2182 0.2196 0.1779 0.1667 0.1355 0.1106 14.66%
Price Multiplier on Financial Quarter End Date
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
Date 30/06/08 29/06/07 30/06/06 30/06/05 30/06/04 30/06/03 28/06/02 -
Price 3.27 3.53 4.51 4.53 4.82 4.07 7.32 -
P/RPS 0.26 0.34 0.48 0.49 0.66 0.66 0.61 -13.23%
P/EPS 5.53 14.86 22.05 11.92 10.46 10.18 9.89 -9.22%
EY 18.10 6.73 4.53 8.39 9.56 9.83 10.11 10.18%
DY 11.01 8.50 5.10 4.64 1.87 0.00 0.00 -
P/NAPS 0.96 1.20 1.52 1.80 2.03 2.09 2.29 -13.47%
Price Multiplier on Announcement Date
30/06/08 30/06/07 30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 CAGR
Date 14/08/08 17/08/07 16/08/06 18/08/05 06/08/04 19/08/03 26/08/02 -
Price 3.44 3.44 4.00 5.00 4.64 4.73 7.86 -
P/RPS 0.28 0.33 0.43 0.54 0.63 0.76 0.66 -13.30%
P/EPS 5.81 14.48 19.56 13.16 10.07 11.83 10.62 -9.55%
EY 17.20 6.91 5.11 7.60 9.94 8.46 9.41 10.56%
DY 10.47 8.72 5.75 4.20 1.94 0.00 0.00 -
P/NAPS 1.01 1.17 1.35 1.99 1.95 2.43 2.46 -13.77%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment